Переносимость физической нагрузки и качество жизни у больных хронической обструктивной болезнью легких. Влияние тиотропия бромида

1. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report, updated 2003.

2. Vincken W., van Noord J., Greefhorst A., et al. Improved health outcome in patients with COPD during lyr's treatment with tiotropium. Eur.Respir. J. 2002; 19: 209-216.

3. Casaburi R., Mahler D., Jones P. et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur. Respir. J. 2002; 19: 217-224.

4. Donohue J.,van Noord J., Bateman E. et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55.

5. O'Donnel D., Magnussen H., Aguilaniu B. et al. Spiriva (tiotropium) improves exercise tolerance in COPD. Am. J. Respir. Crit. Care Med. 2002; 165: 227.

6. O'Donnel D., Magnussen H., Gerken F. et al. Mechanisms of improved exercise tolerance in COPD in response to tiotropium. Eur. Respir. J. 2002; 20: 288s.

7. O'Donnel D., Magnussen H., Aguilaniu B. et al. Spiriva (tiotropium) reduces exertional dyspnea in COPD. Am. J. Respir. Crit. Care Med. 2002; 165: A265.